Your session is about to expire
← Back to Search
Early Motor Experience for Down Syndrome
N/A
Recruiting
Research Sponsored by Georgia State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
An appropriate age range of 7-24 months
Be younger than 18 years old
Must not have
The presence of seizure disorders
Non-correctable vision, hearing and heart problems
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 25 months for all three groups
Awards & highlights
No Placebo-Only Group
Summary
This trial will examine if motor, cognitive, and language development in infants with Down syndrome can be improved with gross and fine motor experience.
Who is the study for?
This trial is for infants aged 7-24 months who have been diagnosed with Down syndrome. It's not suitable for those with seizure disorders, uncorrectable vision or hearing issues, heart problems, or any severe medical conditions that would limit their participation.
What is being tested?
The study is testing the impact of specific motor experiences on development in infants with Down syndrome. It will explore how gross motor (like crawling) and fine motor (like grasping) interventions can influence cognitive and language skills.
What are the potential side effects?
Since this trial involves developmental interventions rather than medications, traditional side effects are not applicable. However, there may be risks associated with physical activity which will be monitored by the researchers.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My child is between 7 and 24 months old.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have a seizure disorder.
Select...
I have vision, hearing, or heart issues that cannot be fixed.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 25 months for all three groups
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~25 months for all three groups
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Bayley cognitive scores
Bayley language scores
Gesture production
Secondary study objectives
Bayley motor scores
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Gross motor interventionExperimental Treatment1 Intervention
Participants will receive a home-based, parent-administered body-weight supported treadmill intervention from about 10 months of age until walking onset.
Group II: Gross and fine motor interventionExperimental Treatment1 Intervention
Besides the body-weight supported treadmill intervention as illustrated above, participants will receive additional fine motor intervention using "sticky mittens" from about 10 months of age for five months.
Group III: ControlActive Control1 Intervention
Participants will not receive specific intervention.
Find a Location
Who is running the clinical trial?
Georgia State UniversityLead Sponsor
65 Previous Clinical Trials
30,661 Total Patients Enrolled
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
2,067 Previous Clinical Trials
2,747,399 Total Patients Enrolled
16 Trials studying Down Syndrome
145,394 Patients Enrolled for Down Syndrome
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have Down syndrome.My child is between 7 and 24 months old.I have a seizure disorder.I have vision, hearing, or heart issues that cannot be fixed.My infant has no severe medical conditions that would prevent participation.
Research Study Groups:
This trial has the following groups:- Group 1: Gross motor intervention
- Group 2: Gross and fine motor intervention
- Group 3: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.